Terms: = Germ cell tumor AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
36 results:
1. Survivals following discontinuation of PD-1 inhibitor treatment in advanced melanoma patients.
Kartolo A; Tong J; Yeung C; Kuksis M; Hopman W; Baetz T
Melanoma Res; 2023 Feb; 33(1):50-57. PubMed ID: 36382411
[TBL] [Abstract] [Full Text] [Related]
2. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
[TBL] [Abstract] [Full Text] [Related]
3. Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approach.
Do DT; Yang MR; Lam LHT; Le NQK; Wu YW
Sci Rep; 2022 Aug; 12(1):13412. PubMed ID: 35927323
[TBL] [Abstract] [Full Text] [Related]
4. Association of dynamic susceptibility contrast- and dynamic contrast-enhanced magnetic resonance imaging parameters with molecular marker status in lower-grade gliomas: A retrospective study.
Ahn SH; Ahn SS; Park YW; Park CJ; Lee SK
Neuroradiol J; 2023 Feb; 36(1):49-58. PubMed ID: 35532193
[TBL] [Abstract] [Full Text] [Related]
5. A comparative study for glioma classification using deep convolutional neural networks.
Özcan H; Emiroğlu BG; Sabuncuoğlu H; Özdoğan S; Soyer A; Saygı T
Math Biosci Eng; 2021 Jan; 18(2):1550-1572. PubMed ID: 33757198
[TBL] [Abstract] [Full Text] [Related]
6. Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy.
Kartolo A; Holstead R; Khalid S; Emack J; Hopman W; Robinson A; Baetz T
Immunotherapy; 2020 Aug; 12(11):785-798. PubMed ID: 32657234
[No Abstract] [Full Text] [Related]
7. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
[TBL] [Abstract] [Full Text] [Related]
8. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
9. Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma.
Bronner SM; Merrick KA; Murray J; Salphati L; Moffat JG; Pang J; Sneeringer CJ; Dompe N; Cyr P; Purkey H; Boenig GL; Li J; Kolesnikov A; Larouche-Gauthier R; Lai KW; Shen X; Aubert-Nicol S; Chen YC; Cheong J; Crawford JJ; Hafner M; Haghshenas P; Jakalian A; Leclerc JP; Lim NK; O'Brien T; Plise EG; Shalan H; Sturino C; Wai J; Xiao Y; Yin J; Zhao L; Gould S; Olivero A; Heffron TP
Bioorg Med Chem Lett; 2019 Aug; 29(16):2294-2301. PubMed ID: 31307887
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis on risk factors of positive vertical resection margin after endoscopic treatment of rectal neuroendocrine tumors].
Wang RG; Jiang X; Ren YT; Wang J; Guo XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):643-647. PubMed ID: 31302962
[No Abstract] [Full Text] [Related]
11. Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.
Richardson TE; Patel S; Serrano J; Sathe AA; Daoud EV; Oliver D; Maher EA; Madrigales A; Mickey BE; Taxter T; Jour G; White CL; Raisanen JM; Xing C; Snuderl M; Hatanpaa KJ
J Neuropathol Exp Neurol; 2019 Jun; 78(6):501-507. PubMed ID: 31034050
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study.
Ito T; Tori M; Hashigaki S; Kimura N; Sato K; Ohki E; Sawaki A; Okusaka T
Jpn J Clin Oncol; 2019 Apr; 49(4):354-360. PubMed ID: 30834940
[TBL] [Abstract] [Full Text] [Related]
13. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
[TBL] [Abstract] [Full Text] [Related]
14. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Dreno B; Thompson JF; Smithers BM; Santinami M; Jouary T; Gutzmer R; Levchenko E; Rutkowski P; Grob JJ; Korovin S; Drucis K; Grange F; Machet L; Hersey P; Krajsova I; Testori A; Conry R; Guillot B; Kruit WHJ; Demidov L; Thompson JA; Bondarenko I; Jaroszek J; Puig S; Cinat G; Hauschild A; Goeman JJ; van Houwelingen HC; Ulloa-Montoya F; Callegaro A; Dizier B; Spiessens B; Debois M; Brichard VG; Louahed J; Therasse P; Debruyne C; Kirkwood JM
Lancet Oncol; 2018 Jul; 19(7):916-929. PubMed ID: 29908991
[TBL] [Abstract] [Full Text] [Related]
15. 131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study.
Kotecka-Blicharz A; Hasse-Lazar K; Handkiewicz-Junak D; Gawlik T; Pawlaczek A; Oczko-Wojciechowska M; Michalik B; Szpak-Ulczok S; Krajewska J; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2018; 69(3):246-251. PubMed ID: 29645065
[TBL] [Abstract] [Full Text] [Related]
16. Anatomic Location Is the Primary Determinant of Survival for Paragangliomas.
Fischer T; Gaitonde S; Jones M; Bandera B; Goldfarb M
Am Surg; 2017 Oct; 83(10):1132-1136. PubMed ID: 29391110
[TBL] [Abstract] [Full Text] [Related]
17. Highly expressed lncRNA ccnd2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling.
Zhang H; Wei DL; Wan L; Yan SF; Sun YH
Biochem Biophys Res Commun; 2017 Jan; 482(4):1219-1225. PubMed ID: 27923660
[TBL] [Abstract] [Full Text] [Related]
18. Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors.
Huang X; Zhang R; Mao Y; Zhou LF; Zhang C
World J Pediatr; 2016 Aug; 12(3):275-282. PubMed ID: 27351562
[TBL] [Abstract] [Full Text] [Related]
19. Investigation of the effects of a sulfite molecule on human neuroblastoma cells via a novel oncogene URG4/URGCP.
Dodurga Y; Seçme M; Eroğlu C; Gündoğdu G; Avcı ÇB; Bağcı G; Küçükatay V; Lale Şatıroğlu-Tufan N
Life Sci; 2015 Dec; 143():27-34. PubMed ID: 26506573
[TBL] [Abstract] [Full Text] [Related]
20. Aloe vera Extract Suppresses Proliferation of Neuroblastoma cells In Vitro.
Yonehara A; Tanaka Y; Kulkeaw K; Era T; Nakanishi Y; Sugiyama D
Anticancer Res; 2015 Aug; 35(8):4479-85. PubMed ID: 26168490
[TBL] [Abstract] [Full Text] [Related]
[Next]
